Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETAPA trial of early targeted paracetamol treatment for patent ductus arteriosus in extremely low birth weight infants
2020-004245-37Phase 3Active
- Sponsor
- University College Dublin
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in patent ductus arteriosus (PDA) comparing Paracetamol with Placebo (2 arms). Primary endpoint: Combined outcome of severe periventricular/intraventricular hemorrhage, necrotizing enterocolitis, and death before discharge. Started Oct 2020; status: active.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on 2020-004245-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004245-37.